EP2094846B8 - Utilisation de tde pour l'isolement d'acides nucléiques - Google Patents

Utilisation de tde pour l'isolement d'acides nucléiques Download PDF

Info

Publication number
EP2094846B8
EP2094846B8 EP07856546.2A EP07856546A EP2094846B8 EP 2094846 B8 EP2094846 B8 EP 2094846B8 EP 07856546 A EP07856546 A EP 07856546A EP 2094846 B8 EP2094846 B8 EP 2094846B8
Authority
EP
European Patent Office
Prior art keywords
tde
isolation
nucleic acids
nucleic
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP07856546.2A
Other languages
German (de)
English (en)
Other versions
EP2094846B1 (fr
EP2094846A1 (fr
Inventor
Horst Donner
Frank Bergmann
Nina Lassonczyk
Marcus Schmid
Manfred Watzele
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Original Assignee
F Hoffmann La Roche AG
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG, Roche Diagnostics GmbH filed Critical F Hoffmann La Roche AG
Priority to EP07856546.2A priority Critical patent/EP2094846B8/fr
Publication of EP2094846A1 publication Critical patent/EP2094846A1/fr
Application granted granted Critical
Publication of EP2094846B1 publication Critical patent/EP2094846B1/fr
Publication of EP2094846B8 publication Critical patent/EP2094846B8/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C12N15/1006Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP07856546.2A 2006-12-13 2007-12-11 Utilisation de tde pour l'isolement d'acides nucléiques Active EP2094846B8 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07856546.2A EP2094846B8 (fr) 2006-12-13 2007-12-11 Utilisation de tde pour l'isolement d'acides nucléiques

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06025779 2006-12-13
EP07856546.2A EP2094846B8 (fr) 2006-12-13 2007-12-11 Utilisation de tde pour l'isolement d'acides nucléiques
PCT/EP2007/010793 WO2008071384A1 (fr) 2006-12-13 2007-12-11 Utilisation de tde pour l'isolement d'acides nucléiques

Publications (3)

Publication Number Publication Date
EP2094846A1 EP2094846A1 (fr) 2009-09-02
EP2094846B1 EP2094846B1 (fr) 2012-09-12
EP2094846B8 true EP2094846B8 (fr) 2013-10-16

Family

ID=38109608

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07856546.2A Active EP2094846B8 (fr) 2006-12-13 2007-12-11 Utilisation de tde pour l'isolement d'acides nucléiques

Country Status (4)

Country Link
US (2) US8124338B2 (fr)
EP (1) EP2094846B8 (fr)
ES (1) ES2394815T3 (fr)
WO (1) WO2008071384A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100708095B1 (ko) * 2000-07-20 2007-04-16 삼성전자주식회사 헤드 짐벌 조립체
EP2094846B8 (fr) * 2006-12-13 2013-10-16 Roche Diagnostics GmbH Utilisation de tde pour l'isolement d'acides nucléiques
EP2163621A1 (fr) * 2008-09-03 2010-03-17 Qiagen GmbH Procédé d'isolation et de nettoyage d'acides nucléiques
EP2264184A1 (fr) * 2009-06-22 2010-12-22 Qiagen GmbH Procédé d'amplification d'ADN en utilisant du tétraéthylèneglycole, coffret de pièces correspondant et son utilisation
EP2345719A1 (fr) * 2010-01-18 2011-07-20 Qiagen GmbH Procédé d'isolation de petit ARN
US9725754B2 (en) 2010-07-29 2017-08-08 Sean F. Boyle Generic sample preparation
JP6169489B2 (ja) 2010-07-29 2017-07-26 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 一般的な試料調製
DK2970878T3 (en) 2013-03-15 2018-09-03 Truckee Applied Genomics Llc PROCEDURES AND REAGENTS FOR MAINTAINING THE LIVELY OF CANCER CELLS IN OPERATIVE REMOVED Tissue
EP3819376A4 (fr) * 2018-07-06 2022-04-20 Daiyukai Health System Composition et procédé pour améliorer l'efficacité d'extraction d'arn de petite taille
CN115379793A (zh) * 2020-04-21 2022-11-22 美国西门子医学诊断股份有限公司 用于临床样本采集和分子诊断应用的运送培养基及其生产和使用方法
CN114213492A (zh) * 2021-09-23 2022-03-22 武汉奥科鼎盛生物科技有限公司 一种dna纯化试剂、其制备方法及dna纯化方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3724442A1 (de) 1987-07-23 1989-02-02 Europ Lab Molekularbiolog Verfahren und vorrichtung zur reinigung von m-13-phagen-dna
US5004543A (en) * 1988-06-21 1991-04-02 Millipore Corporation Charge-modified hydrophobic membrane materials and method for making the same
US5234809A (en) 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
DE4239246C1 (de) * 1992-11-21 1993-12-16 Goldschmidt Ag Th Verfahren zur Herstellung von SiH-Gruppen aufweisenden Organopolysiloxanen
DE4321904B4 (de) 1993-07-01 2013-05-16 Qiagen Gmbh Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
WO1995021849A1 (fr) * 1994-02-11 1995-08-17 Qiagen Gmbh Procede de separation de structures d'acides nucleiques a deux brins et a un brin
DE19538385A1 (de) 1995-10-14 1997-04-17 Deutsche Telekom Ag Verfahren zur Etablierung eines gemeinsamen Schlüssels für autorisierte Personen durch eine Zentrale
US6027945A (en) * 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
US6071745A (en) * 1997-06-27 2000-06-06 Bio-Rad Laboratories Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
DE19743518A1 (de) 1997-10-01 1999-04-15 Roche Diagnostics Gmbh Automatisierbare universell anwendbare Probenvorbereitungsmethode
DE69942866D1 (de) * 1998-06-25 2010-11-25 Hydro Quebec Polymere aus Blockcopolymerisierbaren Monomeren und ihre Verwendung in der Herstellung von Ionenleitern
US6824866B1 (en) * 1999-04-08 2004-11-30 Affymetrix, Inc. Porous silica substrates for polymer synthesis and assays
EP1232502B1 (fr) 1999-11-17 2006-01-11 Roche Diagnostics GmbH Particules de verre magnetiques, procede de preparation et utilisations
JP4115658B2 (ja) * 1999-12-08 2008-07-09 富士フイルム株式会社 セルロース系ポリマーの製造方法
JP3602071B2 (ja) 2001-06-05 2004-12-15 株式会社日立製作所 核酸の精製分離方法
US7148343B2 (en) * 2001-10-12 2006-12-12 Gentra Systems, Inc. Compositions and methods for using a solid support to purify RNA
US20050059024A1 (en) 2003-07-25 2005-03-17 Ambion, Inc. Methods and compositions for isolating small RNA molecules
EP1660631B1 (fr) 2003-08-01 2013-04-24 Life Technologies Corporation Compositions et procedes de purification de courtes molecules d'arn
CA2482097C (fr) 2003-10-13 2012-02-21 F. Hoffmann-La Roche Ag Methodes pour isoler des acides nucleiques
JP3714940B2 (ja) * 2003-11-07 2005-11-09 株式会社日立ハイテクノロジーズ Rna抽出方法、および生体材料の分析方法
US8426126B2 (en) * 2004-03-18 2013-04-23 Applied Biosystems, Llc Modified surfaces as solid supports for nucleic acid purification
US7312036B2 (en) * 2004-03-22 2007-12-25 Isis Pharmaceuticals, Inc. Compositions for use in identification of viral hemorrhagic fever viruses
WO2005103298A2 (fr) * 2004-04-20 2005-11-03 Genaco Biomedical Products, Inc. Procede pour detecter ncrna
US7625758B2 (en) * 2005-01-26 2009-12-01 Berkelman Thomas R Coumarin-based cyanine dyes for non-specific protein binding
EP2094846B8 (fr) * 2006-12-13 2013-10-16 Roche Diagnostics GmbH Utilisation de tde pour l'isolement d'acides nucléiques

Also Published As

Publication number Publication date
ES2394815T3 (es) 2013-02-05
US20100086924A1 (en) 2010-04-08
WO2008071384A1 (fr) 2008-06-19
EP2094846B1 (fr) 2012-09-12
US20110266172A1 (en) 2011-11-03
US8124338B2 (en) 2012-02-28
EP2094846A1 (fr) 2009-09-02

Similar Documents

Publication Publication Date Title
EP2094846B8 (fr) Utilisation de tde pour l'isolement d'acides nucléiques
WO2007126697A8 (fr) Contrôleur de retard pour un générateur de faisceau de réception d'ultrasons
WO2009060191A9 (fr) Systèmes pour essais cliniques
ZA200900336B (en) Process for the preparation of diesters
AU2007312310A1 (en) Phenylacetamides useful as protein kinase inhibitors
GB0910201D0 (en) The preparation method of 2-deoxy-l-ribose
EP2181989B8 (fr) Procédé de préparation d'olopatadine
WO2007111987A8 (fr) Organe de commande de retard pour formateur de faisceau de réception ultrasonore
AU2007270897A8 (en) Novel process for the preparation of bisphosphonic acids
EP2052280B8 (fr) Système permettant l'échange d'informations entre produits
AU2006906520A0 (en) Improved hybridisation of nucleic acids
PL379846A1 (pl) Sposób wyodrębniania 2-metyloepichlorohydryny glicerynowej
AU2006904593A0 (en) Assay for Gene Expression
AU2006903380A0 (en) Telomerase assay
AU2006906349A0 (en) Universal Water
AU2006900042A0 (en) Transfer proteins
AU2006904523A0 (en) Viral polymerase inhibitors
AU2007904700A0 (en) An assay
AU2007901397A0 (en) Assay for Gene Expression
AU2006906900A0 (en) Assay for response to proteasome inhibitors
AU2006905839A0 (en) Vibration Isolation Assembly
AU2006900014A0 (en) Vibration Isolation Assembly
AU2007905117A0 (en) Vibration Isolation Section
AU2006905159A0 (en) Diagnostic assay
AU2006100851A4 (en) FindMe System

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090713

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: SCHMID, MARCUS

Inventor name: WATZELE, MANFRED

Inventor name: LASSONCZYK, NINA

Inventor name: DONNER, HORST

Inventor name: BERGMANN, FRANK

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20100308

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 575116

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120915

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: F.HOFFMANN-LA ROCHE AG

Owner name: ROCHE DIAGNOSTICS GMBH

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: ROCHE DIAGNOSTICS GMBH

Owner name: F.HOFFMANN-LA ROCHE AG

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602007025498

Country of ref document: DE

Effective date: 20121108

RAP2 Party data changed (patent owner data changed or rights of a patent transferred)

Owner name: ROCHE DIAGNOSTICS GMBH

Owner name: F.HOFFMANN-LA ROCHE AG

REG Reference to a national code

Ref country code: NL

Ref legal event code: T3

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2394815

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20130205

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 575116

Country of ref document: AT

Kind code of ref document: T

Effective date: 20120912

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

Effective date: 20120912

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121213

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130112

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20130114

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20121212

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121231

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

26N No opposition filed

Effective date: 20130613

GRAT Correction requested after decision to grant or after decision to maintain patent in amended form

Free format text: ORIGINAL CODE: EPIDOSNCDEC

PLAA Information modified related to event that no opposition was filed

Free format text: ORIGINAL CODE: 0009299DELT

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

R26N No opposition filed (corrected)

Effective date: 20130613

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602007025498

Country of ref document: DE

Effective date: 20130613

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121211

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20120912

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20121211

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20071211

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 9

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20221214

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20231121

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231124

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231122

Year of fee payment: 17

Ref country code: DE

Payment date: 20231121

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240102

Year of fee payment: 17